These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8398315)

  • 21. Myocardial ischemia and infarction associated with vinorelbine.
    Bergeron A; Raffy O; Vannetzel JM
    J Clin Oncol; 1995 Feb; 13(2):531-2. PubMed ID: 7844615
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
    Carabante-Ocón F; Cobo-Dols M; Benavides-Orgaz M; Gil-Calle S; Alés-Díaz I; Bretón-García JJ; Villar-Chamorro E; Montesa-Pino A; Alcalde-García J; Gutiérrez-Calderón V
    Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Localized epidermal necrolysis after intravenous injection of vinorelbine].
    Misery L; Perrot JL; Vergnon JM; Boucheron S; Emonot A; Claudy A
    Presse Med; 1992 Dec 19-26; 21(44):2153. PubMed ID: 1297136
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.
    Twelves CJ; Dobbs NA; Curnow A; Coleman RE; Stewart AL; Tyrrell CJ; Canney P; Rubens RD
    Br J Cancer; 1994 Nov; 70(5):990-3. PubMed ID: 7947109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].
    Yokota Y; Suzuki T; Narahashi T; Takizawa J; Kojima M; Shimada R
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1525-9. PubMed ID: 18799905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 27. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinorelbine therapy in a hemodialyzed patient.
    Rollino C; Milongo R; Schaerer R; Cordonnier D
    Nephron; 1992; 61(2):232-3. PubMed ID: 1630554
    [No Abstract]   [Full Text] [Related]  

  • 29. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the antitumour activity of vinorelbine in breast cancer.
    Marty M; Extra JM; Dieras V; Giacchetti S; Ohana S; Espié M
    Drugs; 1992; 44 Suppl 4():29-35; discussion 66-9. PubMed ID: 1283848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer].
    Suehisa H; Aogi K; Hara F; Takabatake D; Takashima S; Ohsumi S; Takashima S; Komatsubara K
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1709-12. PubMed ID: 18931573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.
    Thallinger C; Lang I; Kuhar CG; Bartsch R; Singer CF; Petruzelka L; Melichar B; Knittelfelder R; Brodowicz T; Zielinski C
    BMC Cancer; 2016 Feb; 16():121. PubMed ID: 26887956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
    George MJ; Heron JF; Kerbrat P; Chauvergne J; Goupil A; Lebrun D; Guastalla JP; Namer M; Bugat R; Ayme Y
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):30-2. PubMed ID: 2652318
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation recall with vinorelbine and cisplatin.
    Zhu ZF; Fan M; Fu XL
    Onkologie; 2010; 33(3):107-9. PubMed ID: 20215801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible drug interaction between itraconazole and vinorelbine tartrate leading to death after one dose of chemotherapy.
    Bosque E
    Ann Intern Med; 2001 Mar; 134(5):427. PubMed ID: 11242511
    [No Abstract]   [Full Text] [Related]  

  • 38. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.
    Keller S; Seipel K; Novak U; Mueller BU; Taleghani BM; Leibundgut K; Pabst T
    Leuk Res; 2015 Jul; 39(7):786-92. PubMed ID: 25891070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.